Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that the Company will host Investor Conference Call on Thursday, November 6, 2025 at 06:00 pm (IST) for Q2 & H1 FY26. Details of the Investor Conference Call are enclosed. The same are also being uploaded on website of the Company at www.mankindpharma.com.
The above information is a part of company’s filings submitted to BSE.